NANCY LANCE: Open Payments
NPI 1356430417 · FROESTVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$441 in 22 payments from 8 companies in 2025. Trend: 2023 $218 · 2024 $604 · 2025 $441
Food & beverage: $441
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 7 | $118 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $114 |
| Novo Nordisk Inc | 4 | $80 |
| Exact Sciences Corporation | 2 | $45 |
| Lilly USA, LLC | 2 | $31 |
| Dexcom, Inc. | 1 | $23 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Amgen Inc. | 1 | $15 |
Products named: TRELEGY ELLIPTA, CAPLYTA, MOUNJARO, The Cologuard Plus Collection Kit, Rybelsus, Dexcom G6 Transmitter, Cologuard Collection Kit, NUZYRA.
Industry payments across NY — which companies pay providers there.
